Replies to post #595896 on NorthWest Biotherapeutics Inc (NWBO)

[CrashOverride]

If Marnix Bosch appeared at the White House how many erroneous lawsuits and complaints would be filed arguing that Northwest Biotherapeutics are advertising an unapproved drug?

This tactic was already attempted to block UK approval.

I don't think management think this White House forum really matters since we already have these stakeholders behind DCVax:


FDA
MHRA
JAMA
Hundreds of top oncologists
Countless patient advocacy groups


Ultimately what's important? Approval not some roundtable on YouTube.

We are the only game in town for rGBM and nGBM.

Period!

[hoffmann6383]

It tells me all I need to know about NWBO's chances

I hear this narrative daily - there is no hope for dcvax. Yet, if shareholders truly believed this then there would be no point in repeating the same claim daily for years on end. Obviously, there is hope and the repeated narrative is designed to crush that hope.

have a good one Less!

[Dan88]

Exactly right LessIsMore, the earlier in the development of a company, the better chance of being invited to today's moonshot discussion; NWBO is in the process of preparations for regulatory approvals or in the process of regulatory approval, so of course NWBO should not be invited to the discussion, otherwise FDA should be disbanded.

One more example of the above argument is Kazia Therapeutics whose CEO is invited to the discussion as well, which has participated in the global GBM AGILE trial (NCT03970447) with primary completion day of June 2026, contrary to Kazia CEO's claim that its data will be available this year.

The fact is no companies whose trials are completed with positive outcomes are invited to the discussion so you better focus your efforts in reading financial filing, not anything else.

As for whether there is any hint relevant to NWBO from this afternoon's discussion, you will definitely have some as nobody can circumvent NWBO's achievement in this field: soon to be approved paradigm shift caner vaccine DCVax-L, just don't bet on direct name calling.